Why Aren't Allergy Drops Covered by Insurance?
Allergy drops aren't covered because of how they're regulated, not how well they work. Compounded multi-allergen liquid drops are used off-label and are not FDA-approved, and insurers systematically exclude off-label and investigational treatments. Only FDA-approved sublingual tablets clear that bar. Understanding the FDA-approval pathway and payer medical-policy logic explains the coverage gap completely.
5 peer-reviewed sources
Because they're compounded and used off-label, not FDA-approved. Insurers exclude off-label treatments as a matter of policy, regardless of clinical value, which is why coverage is consistent across payers.
Medically reviewed by Dr. Chet Tharpe, M.D. · Last reviewed June 2026
Key facts
Allergy drops are not covered because the sublingual route for compounded multi-allergen extracts is used off-label and is not FDA-approved.
Payers generally reimburse only FDA-approved treatments, and the only approved SLIT products are tablets, not compounded drops.
Compounded drops also lack a dedicated immunotherapy reimbursement code, so payers have no claim to adjudicate.
Despite the coverage gap, allergy drops remain HSA/FSA-eligible, so the $39-$99/month cost can be paid pre-tax.
The Real Reason Behind the Coverage Gap
Patients often assume their insurer is being stingy, but the reason allergy drops aren't covered is structural and applies almost identically across every payer. Custom liquid allergy drops are compounded — mixed to order from FDA-approved allergen extracts — but the resulting multi-allergen sublingual preparation has not itself been approved by the FDA for that use. That makes it an off-label treatment, and insurers maintain medical policies that systematically exclude off-label and investigational therapies from coverage. The exclusion is about regulatory category, not clinical merit; a treatment can have supportive evidence and still be uncovered simply because it has not gone through the approval pathway that would change its category. This is why the answer is the same whether you have a commercial plan, Medicare, or Medicaid. Before any treatment decision, identifying your actual triggers matters; at-home allergy testing from Curex maps your IgE sensitization profile so your provider can determine whether an approved tablet fits or whether off-label drops are the clinical match. The sections below unpack the FDA-approval mechanics, how compounding fits in, and the payer medical-policy logic that ties it all together.
Coverage tracks regulatory status, not effectiveness. Off-label means excluded by policy — so the gap is consistent across insurers and won't be fixed by switching plans.
Ready to skip the needles?
See if at-home allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, taken under the tongue daily with no clinic visits.
- AllergistReviewed & prescribed
- $39/moWith insurance
- No needlesUnder the tongue
- HSA/FSAEligible
No needles. No clinic visits.
Curex's allergy drops are taken under the tongue at home, daily — from $39/month with insurance (or $99/month self-pay), with no needles and no routine clinic visits.
Allergy drops are compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
See if allergy drops are right for youOn-Label vs Off-Label: Why One Is Covered and One Isn't
The clearest way to understand the coverage gap is to compare an off-label compounded drop with an on-label approved tablet across the regulatory dimensions payers actually use. The difference is not effectiveness in any given patient but whether the product has cleared the FDA pathway that insurers tie coverage to. This framing also explains why a covered tablet may not suit you clinically even though it is cheaper after coverage.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
Compounded Liquid DropsBest | Moderate-grade evidence; multi-allergen capable | 3-5 years, daily at home | Self-pay; off-label exclusion applies; HSA/FSA-eligible | Several allergens at once, no clinic visits | Mostly mild local oral reactions |
FDA-Approved Tablet | Strong phase-3 evidence, one allergen each | 3-5 years, daily at home | Covered as a pharmacy drug after prior auth | Daily; single-allergen limit | Boxed warning; mostly local reactions |
In-Office Allergy Shots | Strong evidence across allergens | 3-5 years, clinic visits | Covered as an administered medical service | Regular injections with observation | Higher systemic-reaction risk |
- Efficacy
- Moderate-grade evidence; multi-allergen capable
- Duration
- 3-5 years, daily at home
- Cost (5yr)
- Self-pay; off-label exclusion applies; HSA/FSA-eligible
- Convenience
- Several allergens at once, no clinic visits
- Safety
- Mostly mild local oral reactions
- Efficacy
- Strong phase-3 evidence, one allergen each
- Duration
- 3-5 years, daily at home
- Cost (5yr)
- Covered as a pharmacy drug after prior auth
- Convenience
- Daily; single-allergen limit
- Safety
- Boxed warning; mostly local reactions
- Efficacy
- Strong evidence across allergens
- Duration
- 3-5 years, clinic visits
- Cost (5yr)
- Covered as an administered medical service
- Convenience
- Regular injections with observation
- Safety
- Higher systemic-reaction risk
Curex offers personalized compounded sublingual allergy drops prescribed by a board-certified allergist for $39/month with insurance covering the clinical visits, or $99/month self-pay — and because the off-label drops aren't reimbursed, the HSA/FSA-eligible subscription is the practical way to manage the cost. Allergy drops are compounded at a specialty pharmacy for each patient. The FDA does not review compounded products for safety or efficacy.
See if allergy drops are right for youWhat the Coverage Gap Means for Your Wallet
Because the exclusion is rooted in regulatory category, the cost consequence is predictable: you pay for the drops yourself, generally around $99 per month, while insurance may still cover the testing and visits that fall under standard medical benefits. The line items below show how the off-label status routes each component. Approved tablets, which clear the regulatory bar, are the exception that proves the rule — they run through your pharmacy benefit instead of being excluded.
| Item | With Insurance | Self-Pay |
|---|---|---|
| Compounded liquid drops (off-label) | Excluded by medical policy | $99/mo ($990/yr) |
| FDA-approved tablet (on-label) | Often covered with prior auth | Pharmacy copay |
| Allergy testing (diagnostic) | Usually covered | Sometimes bundled |
| Specialist consult | Usually covered | Varies |
| Total | Testing/visits only | $99/mo for the drops |
Cost Comparison
- Off-label status won't change by appealing, since it's a category exclusion, not a denial of a covered service
- Approved tablets each cover one allergen, limiting their fit for multiple triggers
How Payer Medical Policy Creates the Exclusion
Insurers publish medical policies that define which treatments are covered, and a near-universal clause excludes services that are experimental, investigational, or off-label. Compounded multi-allergen sublingual drops fall squarely into the off-label category because the FDA has not approved that specific preparation and route, even though the underlying extracts are approved. The FDA-approval pathway is what moves a product from off-label to on-label: a manufacturer runs controlled trials, files for approval of a defined indication, and once granted, the product becomes eligible for standard coverage. The four approved SLIT tablets went through exactly this process; compounded drops have not, which is why the exclusion is consistent across commercial plans, Medicare, and Medicaid. Appeals rarely succeed against a category exclusion because nothing about an individual case changes the product's regulatory status.
Note: Same logic across Aetna, Cigna, BCBS, UnitedHealthcare
Off-label/investigational exclusion clause
Note: Part D may cover approved tablets
Off-label drops not a covered benefit
Note: State formularies follow FDA status
Off-label drops typically excluded statewide
- HSA/FSA eligible (pre-tax)
- Self-pay $99/mo for the drops
- Pursue an approved tablet if one matches your allergen
Curex allergy drops start at $39/month with insurance (or $99/month self-pay) — HSA/FSA eligible.
Start free assessmentFrequently asked questions
What does off-label mean for allergy drops?
Off-label means a medication or preparation is being used in a way the FDA has not formally approved, even if the components are themselves approved. For allergy drops, the individual allergen extracts are FDA-approved, but mixing them into a multi-allergen liquid for sublingual use has not been approved as a specific product and indication. Off-label use is legal and common across medicine when supported by clinical judgment, but it carries a financial consequence: insurers maintain medical policies that exclude off-label and investigational treatments from coverage. That is the central reason allergy drops are typically self-pay. It is a category distinction, not a comment on whether the treatment can help a given patient.
If the extracts are FDA-approved, why aren't the drops covered?
Approval applies to a specific product, formulation, route, and indication, not to the ingredients in the abstract. The allergen extracts used to compound drops are approved for certain uses, but combining several into a custom multi-allergen liquid for sublingual administration is a different preparation that the FDA has not approved. Insurers tie coverage to a product's approved status, so the compounded result is treated as off-label and excluded. This is why the four approved sublingual tablets, which went through the full approval process as defined products, are covered while compounded drops made from approved extracts are not. The distinction is between approved ingredients and an approved finished product.
Will appealing my insurance denial work for allergy drops?
It rarely does, and understanding why saves time. An appeal is most effective when a covered service was wrongly denied for an individual reason, such as a documentation gap or a medical-necessity question. Allergy drops, however, are excluded as a category because they are off-label, not denied on a case-by-case basis. Nothing about your individual circumstances changes the product's regulatory status, so appeals against a blanket off-label exclusion seldom succeed. A more productive path is to ask whether an FDA-approved tablet matches your primary allergen, since approved products are covered, and to use HSA or FSA funds for the compounded drops if a tablet is not a good clinical fit.
Do all insurance companies treat allergy drops the same way?
Largely, yes, and that consistency is itself a clue to the cause. Because the exclusion stems from the drops' off-label regulatory status rather than any single insurer's policy preferences, the major commercial plans, Medicare, and most state Medicaid programs all generally decline to cover compounded liquid drops. Where plans do differ is in the details of testing coverage, specialist-visit copays, and which FDA-approved tablets sit on their formularies. So switching insurers will not unlock coverage for the drops themselves, but it can change what you pay for the surrounding services. The reliable cost lever across any plan is using pre-tax HSA or FSA dollars for the drops.
Could allergy drops become covered in the future?
Potentially, but only through the regulatory pathway. For compounded multi-allergen sublingual drops to become routinely covered, a defined product would generally need to complete FDA approval for a specific indication, which would move it from off-label to on-label and make it eligible under standard medical policies. That is a substantial undertaking involving controlled trials and regulatory review. In the meantime, the FDA-approved single-allergen tablets already occupy the covered space, and they expand over time as new products are approved. Until a compounded multi-allergen product clears approval, expect liquid drops to remain a self-pay, HSA/FSA-eligible treatment rather than a covered benefit.
Related Articles
Allergy Drops vs Allergy Shots: A Cost Comparison
Allergy drops vs shots cost: drops run about $39-99/month while clinic shots reach $167-417/month plus visit time. See the full breakdown.
Read moreAre Allergy Drops Covered by Insurance?
Allergy drops are usually not covered by insurance because they are off-label. Learn what IS sometimes covered, plus the HSA/FSA path to save.
Read moreAllergy Drops Cost Without Insurance
Allergy drops without insurance run about $99/month or $990/year. See how to budget for a full course and stretch the cost with HSA/FSA dollars.
Read moreHow Much Do Allergy Drops Cost Without Insurance?
Without insurance, allergy drops cost about $99/month, $990/year, or roughly $4,950 over a 5-year course. See exact price scenarios by situation.
Read moreDoes Insurance Cover Sublingual Immunotherapy?
Coverage for sublingual immunotherapy splits by product: FDA-approved tablets are often covered, compounded liquid drops usually are not. Full breakdown.
Read moreAre Allergy Drops FSA Eligible?
Are allergy drops FSA eligible? Yes, sublingual immunotherapy qualifies. Learn FSA rules, the use-it-or-lose-it deadline, and how FSAs differ from HSAs.
Read moreTreat your allergies — drops under the tongue.
Curex allergy drops are a personalized sublingual extract, prescribed by a board-certified allergist and shipped to your door — taken daily at home with no needles and no routine clinic visits. From $39/month with insurance, or $99/month self-pay. HSA/FSA eligible.
From $39/mo with insurance · No needles · HSA/FSA eligible · Cancel anytime
Allergy drops are compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Allergy drops are compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
The only FDA-approved sublingual immunotherapy products are tablets — Grastek, Oralair, Ragwitek, and Odactra — which are different from Curex drops.